BeiGene Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

DB:49BA Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
09 May 25	Sell€18,258,936	HHLR Advisors, Ltd.	Company	1,230,769.23	€14.84
25 Mar 25	Sell€10,661,854	Capital Research and Management Company	Company	45,777.26	€232.91
04 Mar 25	Sell€1,969,305	Xiaodong Wang	Individual	8,146	€244.44
28 Feb 25	Sell€183,123,208	Baker Bros. Advisors LP	Company	732,827	€249.89
21 Feb 25	Sell€1,230,611	Wang Lai	Individual	5,000	€248.93
09 Dec 24	Sell€7,278,081	Baker Bros. Advisors LP	Company	37,017	€196.61
09 Dec 24	Sell€176,279,800	Baker Bros. Advisors LP	Company	1,000,000	€176.28
02 Dec 24	Sell€3,400,423,650	HHLR Advisors, Ltd.	Company	17,842,500	€190.58
01 Nov 24	Sell€9,628,783	Capital Research and Management Company	Company	50,971.7	€188.90
08 Oct 24	Sell€2,117,347	John Oyler	Individual	10,000	€215.52
27 Sep 24	Sell€986,859	Wang Lai	Individual	5,000	€197.37
03 Sep 24	Sell€23,571	Titus Ball	Individual	137	€172.05
30 Jul 24	Sell€123,965	Chan Lee	Individual	834	€148.64
09 Jul 24	Sell€2,240,663	Capital Research and Management Company	Company	218,414.99	€10.26
01 Jul 24	Sell€63,341	Julia A. Wang	Individual	472	€134.20
24 Jun 24	Sell€414,849	John Oyler	Individual	2,789	€149.25
24 Jun 24	Sell€217,304	Xiaobin Wu	Individual	1,459	€150.32
24 Jun 24	Sell€130,437	Julia A. Wang	Individual	899	€145.09
24 Jun 24	Sell€158,485	Wang Lai	Individual	1,064	€150.16
18 Jun 24	Sell€342,795	Wang Lai	Individual	2,341	€148.88
18 Jun 24	Sell€470,399	Xiaobin Wu	Individual	3,254	€148.04
17 Jun 24	Sell€65,240	Chan Lee	Individual	439	€148.97
17 Jun 24	Sell€190,367	John Oyler	Individual	1,281	€149.13
17 Jun 24	Sell€135,859	Julia A. Wang	Individual	916	€148.97

Insider Trading Volume

Insider Buying: 49BA insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of 49BA?
Owner Type	Number of Shares	Ownership Percentage
Employee Share Scheme	138,240	0.128%
Private Companies	379,498	0.351%
Individual Insiders	5,051,647	4.67%
General Public	11,790,835	10.9%
Hedge Funds	18,349,874	17%
Public Companies	18,938,119	17.5%
Institutions	53,502,154	49.5%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 76.13% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
17.5%	Amgen Inc.	18,938,119	€4.0b	0%	no data
17%	Baker Bros. Advisors LP	18,349,874	€3.8b	-3.84%	34.85%
5.46%	Capital Research and Management Company	5,903,798	€1.2b	-59.2%	0.06%
4.87%	HHLR Advisors, Ltd.	5,271,713	€1.1b	-13.6%	17.42%
4.67%	PRIMECAP Management Company	5,055,504	€1.1b	-0.85%	0.9%
3.77%	John Oyler	4,080,076	€855.0m	1.51%	no data
3.51%	Baillie Gifford & Co.	3,796,007	€795.5m	-1.06%	0.39%
3.17%	FMR LLC	3,430,836	€718.9m	87.7%	0.05%
2.64%	BlackRock, Inc.	2,857,610	€598.8m	-3.36%	0.01%
2.51%	T. Rowe Price Group, Inc.	2,713,671	€568.7m	-7.62%	0.06%
2.3%	The Vanguard Group, Inc.	2,486,625	€521.1m	1.53%	0.01%
1.06%	Bosera Asset Management Co., Ltd.	1,150,829	€241.2m	0%	1.22%
0.96%	Hillhouse Investment Management, Ltd.	1,034,485	€216.8m	0%	1.94%
0.92%	Temasek Holdings (Private) Limited	993,752	€208.2m	-34.9%	0.17%
0.91%	Citadel Advisors LLC	982,161	€205.8m	210%	0.23%
0.7%	Xiaodong Wang	756,328	€158.5m	0%	no data
0.66%	GF Fund Management Co., Ltd.	717,621	€150.4m	0.04%	0.38%
0.62%	Paradigm Biocapital Advisors LP	666,024	€139.6m	8.12%	7.5%
0.56%	Candriam, Société En Commandite Par Actions	607,530	€127.3m	88.9%	0.4%
0.46%	Artal Group S.A.	498,689	€104.5m	-23.7%	4.14%
0.44%	Marshall Wace LLP	477,143	€100.0m	1,430%	0.16%
0.4%	China Asset Management Co. Ltd.	427,763	€89.6m	-4.54%	0.13%
0.37%	ICBC Credit Suisse Asset Management Co., Ltd.	398,099	€83.4m	0%	0.71%
0.34%	Guangzhou Development District Holding Group Limited	368,385	€77.2m	0%	no data
0.34%	SDIC Chuangyi Industry Fund Management Co., Ltd.	368,385	€77.2m	0%	10.92%

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/05/22 00:28
End of Day Share Price	2025/05/22 00:00
Earnings	2025/03/31
Annual Earnings	2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

BeiGene, Ltd. is covered by 65 analysts. 34 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Brian Skorney	Baird
Michael Meng	BOCI Research Ltd.
Yonglin Yan	BOCI Research Ltd.